Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-047705
Filing Date
2025-03-31
Accepted
2025-03-31 16:09:38
Documents
5
Effectiveness Date
2025-03-31

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_evergreen_shares_202.htm S-8 136552
2 WH CONSENT cue-ex5_1.htm EX-5.1 22817
3 RSM CONSENT cue-ex23_2.htm EX-23.2 4959
4 EX-FILING FEES cue-exfiling_fees.htm EX-FILING FEES 58925
5 GRAPHIC img152828397_0.jpg GRAPHIC 9385
  Complete submission text file 0000950170-25-047705.txt   237419
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286258 | Film No.: 25793263
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)